CAPTRUST Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-16,953
Closed -$399K – 2357
2024
Q4
$399K Sell
16,953
-2,012
-11% -$49.5K ﹤0.01% 1735
2024
Q3
$485K Buy
+18,965
New +$483K ﹤0.01% 1587
2024
Q2
– Sell
-13,565
Closed -$390K – 2201
2024
Q1
$390K Sell
13,565
-4,040
-23% -$121K ﹤0.01% 1622
2023
Q4
$578K Sell
17,605
-476
-3% -$12.9K ﹤0.01% 1646
2023
Q3
$504K Sell
18,081
-5,145
-22% -$168K ﹤0.01% 1644
2023
Q2
$792K Buy
23,226
+10,612
+84% +$334K ﹤0.01% 1349
2023
Q1
$379K Sell
12,614
-7,747
-38% -$240K ﹤0.01% 1568
2022
Q4
$575K Buy
20,361
+4,570
+29% +$145K ﹤0.01% 1266
2022
Q3
$519K Sell
15,791
-18,297
-54% -$672K ﹤0.01% 1225
2022
Q2
$1.07M Buy
34,088
+25,109
+280% +$878K 0.01% 800
2022
Q1
$412K Sell
8,979
-7,928
-47% -$378K ﹤0.01% 1244
2021
Q4
$1.03M Sell
16,907
-6,296
-27% -$435K 0.01% 801
2021
Q3
$1.73M Buy
23,203
+5,937
+34% +$498K 0.01% 557
2021
Q2
$1.6M Buy
17,266
+821
+5% +$69.8K 0.01% 562
2021
Q1
$1.46M Buy
16,445
+10,216
+164% +$1.01M 0.02% 551
2020
Q4
$581K Buy
6,229
+5,453
+703% +$434K 0.01% 780
2020
Q3
$50K Buy
776
+334
+76% +$19.6K ﹤0.01% 1624
2020
Q2
$24K Buy
+442
New +$19K ﹤0.01% 1866

Other funds holding ARKG

CAPTRUST Financial Advisors's ARKG Position: Q1 2025 in Review

CAPTRUST Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 16,953 shares — an estimated $399K sold.

CAPTRUST Financial Advisors first reported a position in ARKG in Q2 2020 and held it in 18 quarters. The position peaked at $1.73M in Q3 2021. 217 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • CAPTRUST Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 16,953 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $399K.
  • CAPTRUST Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 18 quarters.
  • CAPTRUST Financial Advisors's ARK Genomic Revolution ETF position peaked at $1.73M in Q3 2021.
  • 217 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2025, filed 15 May 2025.